Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2021

Open Access 01-12-2021 | Venous Thrombosis | Case report

Cerebral venous thrombosis in a patient with Down syndrome and coronavirus disease 2019: a case report

Authors: Henry Robayo-Amortegui, Natalia Valenzuela-Faccini, Cesar Quecano-Rosas, Darlyng Zabala-Muñoz, Michel Perez-Garzon

Published in: Journal of Medical Case Reports | Issue 1/2021

Login to get access

Abstract

Background

The new coronavirus disease 2019 pandemic has spread throughout most of the world. Cerebral venous thrombosis is a rare thromboembolic disease that can present as an extrapulmonary complication in coronavirus disease 2019 infection.

Case presentation

We report the case of a Hispanic woman with Down syndrome who has coronavirus disease 2019 and presents as a complication extensive cerebral venous thrombosis.

Conclusions

Cerebral venous thrombosis is a rare thromboembolic disease that can present as an extrapulmonary complication in coronavirus disease 2019 infection. In the absence of clinical and epidemiological data, it is important to carry out further investigation of the risk factors and pathophysiological causes related to the development of cerebrovascular thrombotic events in patients with Down syndrome with coronavirus disease 2019 infection.
Literature
2.
go back to reference Shahjouei S, Naderi S, Li J, et al. Risk of stroke in hospitalized SARS-CoV-2 infected patients: a multinational study. EBioMedicine. 2020;59:102939. Shahjouei S, Naderi S, Li J, et al. Risk of stroke in hospitalized SARS-CoV-2 infected patients: a multinational study. EBioMedicine. 2020;59:102939.
3.
go back to reference Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–7.CrossRef Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–7.CrossRef
4.
go back to reference Idiculla PS, Gurala D, Palanisamy M, et al. Cerebral venous thrombosis: a comprehensive review. Eur Neurol 2020; 83:369–79. Idiculla PS, Gurala D, Palanisamy M, et al. Cerebral venous thrombosis: a comprehensive review. Eur Neurol 2020; 83:369–79.
5.
go back to reference Libby P, Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41:3038–44.CrossRef Libby P, Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41:3038–44.CrossRef
6.
go back to reference Espinosa JM. Down syndrome and COVID-19: a perfect storm? Cell Rep Med. 2020;1:100019.CrossRef Espinosa JM. Down syndrome and COVID-19: a perfect storm? Cell Rep Med. 2020;1:100019.CrossRef
7.
go back to reference Uluduz D, Sahin S, Duman T, et al. Cerebral venous sinus thrombosis in women: subgroup analysis of the VENOST Study. Stroke Res Treat. 2020; 8610903. Uluduz D, Sahin S, Duman T, et al. Cerebral venous sinus thrombosis in women: subgroup analysis of the VENOST Study. Stroke Res Treat. 2020; 8610903.
8.
go back to reference Barboza MA, Chiquete E, Arauz A, et al. A practical score for prediction of outcome after cerebral venous thrombosis. Front Neurol. 2018;9:882.CrossRef Barboza MA, Chiquete E, Arauz A, et al. A practical score for prediction of outcome after cerebral venous thrombosis. Front Neurol. 2018;9:882.CrossRef
9.
go back to reference Ulivi L, Squitieri M, Cohen H, Cowley P, Werring DJ. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020;20(5):356–67.CrossRef Ulivi L, Squitieri M, Cohen H, Cowley P, Werring DJ. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020;20(5):356–67.CrossRef
10.
go back to reference Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology. Eur J Neurol 2017;24:1203–13. Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology. Eur J Neurol 2017;24:1203–13.
11.
go back to reference Xu W, Gao L, Li T, et al. The performance of CT versus MRI in the differential diagnosis of cerebral venous thrombosis. Thromb Haemost 2018;118:1067–77. Xu W, Gao L, Li T, et al. The performance of CT versus MRI in the differential diagnosis of cerebral venous thrombosis. Thromb Haemost 2018;118:1067–77.
12.
go back to reference Qureshi A, Perera A. Low molecular weight heparin versus unfractionated heparin in the management of cerebral venous thrombosis: a systematic review and meta-analysis. Ann Med Surg (Lond). 2017;17:22–6.CrossRef Qureshi A, Perera A. Low molecular weight heparin versus unfractionated heparin in the management of cerebral venous thrombosis: a systematic review and meta-analysis. Ann Med Surg (Lond). 2017;17:22–6.CrossRef
13.
go back to reference Santoro JD, Pagarkar D, Chu DT, et al. Neurologic complications of down syndrome: a systematic review. J Neurol. 2020. Santoro JD, Pagarkar D, Chu DT, et al. Neurologic complications of down syndrome: a systematic review. J Neurol. 2020.
Metadata
Title
Cerebral venous thrombosis in a patient with Down syndrome and coronavirus disease 2019: a case report
Authors
Henry Robayo-Amortegui
Natalia Valenzuela-Faccini
Cesar Quecano-Rosas
Darlyng Zabala-Muñoz
Michel Perez-Garzon
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2021
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-021-02908-0

Other articles of this Issue 1/2021

Journal of Medical Case Reports 1/2021 Go to the issue